Skip to main content

Table 3 Predictive value of eGDR for the risk of MACCE

From: Predictive worth of estimated glucose disposal rate: evaluation in patients with non-ST-segment elevation acute coronary syndrome and non-diabetic patients after percutaneous coronary intervention

 

As nominal variatea

As continuous variateb

HR (95% CI)

P value

HR (95% CI)

P value

Unadjusted

1.668 (1.330–2.093)

 < 0.001

1.194 (1.131–1.260)

 < 0.001

Model 1

1.554 (1.213–1.992)

 < 0.001

1.260 (1.171–1.357)

 < 0.001

Model 2

1.442 (1.125–1.848)

0.004

1.224 (1.137–1.317)

 < 0.001

Model 3

1.651 (1.178–2.313)

0.004

1.485 (1.324–1.665)

 < 0.001

Model 4

1.557 (1.124–2.158)

0.008

1.337 (1.201–1.488)

 < 0.001

  1. Model 1: adjusted for age, sex, BMI
  2. Model 2: adjusted for variates in Model 1 and previous MI, previous PCI, previous stroke, smoking history, family history of CAD
  3. Model 3: adjusted for variates in Model 2 and TG, TC, HDL-C, eGFR, hs-CRP, LVEF, ACEI/ARB at discharge
  4. Model 4: adjusted for variates in Model 3 and LM lesion, bifurcation, multi-vessel lesion, in-stent restenosis, chronic total occlusion lesion, SYNTAX score, LM treatment, LAD treatment, LCX treatment, RCA treatment, complete revascularization, number of DES
  5. eGDR estimated glucose disposal rate, MACCE major adverse cardio-cerebral events, HR hazard ratio, CI confidence interval
  6. aThe HR was evaluated regarding the higher median of eGDR as reference
  7. bThe HR was evaluated by per 1-unit decrease of eGDR